Securities Issuance. with the execution of this Agreement, Scopus will issue to COH (or its designees) stock certificates evidencing 200,000 validly issued, fully-paid, non-assessable shares of Common Stock and 47,965 Series X Warrants collectively representing an ownership interest of 1.1% of Scopus on a fully diluted basis, including all warrants, stock options, or other derivatives outstanding and available for grant, as of May 29, 2020 (after giving effect to the Acquisition and the issuance of these shares of Common Stock and these Series X Warrants) (COH and its designees collectively, the “COH Stockholders”).
Appears in 3 contracts
Sources: Exclusive License Agreement (Scopus BioPharma Inc.), Conditional Stock Purchase Agreement (Scopus BioPharma Inc.), Exclusive License Agreement (Scopus BioPharma Inc.)